IL6 and hydrops fetalis: C-reactive protein, lactate dehydrogenase, N-terminal pro–B-type natriuretic peptide, and interleukin-6, which are used to evaluate COVID-19 severity, may already be increased in HF patients, including patients on LVAD support.